Episode Player
How Weight Loss Medications Actually Work in Your Body
Mindfully Integrative Show
We break down the mechanism of action for GLP-1 receptor agonists like tirzepatide (Zepbound/Mounjaro) and semaglutide, explaining how these medications work in the body to regulate appetite and metabolism.
• GLP-1 medications contain a C20 fatty diacid that binds to albumin, prolonging half-life
• These drugs target both GIP and GLP-1 receptors to regulate appetite and caloric intake
• Receptors are found in brain areas involved in appetite regulation and throughout the GI system
• Pharmacodynamics include increased insulin sensitivity, reduced glucagon secretion, and delayed gastric emptying
• Medications are absorbed subcutaneously with about 80% bioavailability
• Distribution occurs throughout the body with 5-6 day half-life, explaining weekly dosing
• Metabolism occurs primarily through the liver with excretion via urine
• Common injection sites include arms, legs, stomach, or back (the "margarita" zones)
Never do this on your own without real supervision. Everything has to be done safely, with a healthcare provider and someone that is aware of where you stand and how you are.
Sponsor Affiliates
Empowering Your Health
Get YOUR Own
Joburg Protein Snacks
Discount Code: Damaris15 Or Damaris18
Feeling need to Lose Weight & Become metabolically Healthy
GET METABOLIC COURSE GLP 1 REseT
This course is designed for individuals looking to optimize their metabolic health through integrative and functional medicine approaches. Whether you're on a GLP-1 medication or seeking natural ways to enhance your metabolic function, this course provides actionable steps, expert insights, and a personalized roadmap sustainable wellness.
Are you feeling stressed, tired, or Metabolism imbalanced?
Take advantage of our free mindful steps to help improve your well-being.
ENJOY ONE OF our Books
Mindful Ways Health Wealth & Life
https://stan.store/Mindfullyintegrative
Join Yearly membership ALL IN ONE FUNCTION HEALTH
Ask Us for help with Medica...
